Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits

Michelle Hawkins, I. T. Taylor, A. L. Craigmill, Lisa A Tell

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The enantioselective pharmacokinetics of single dose (2 mg/kg) racemic carprofen (CPF) were evaluated in adult New Zealand white rabbits after intravenous (i.v.) and subcutaneous (s.c.) dose. Six rabbits were utilized in a two-way randomized crossover study and serial blood samples were collected. Plasma CPF concentrations were determined by high-performance liquid chromatography. After i.v. and s.c. racemic CPF administration, plasma concentration-time curves were best described by a two-compartment open model and a one-compartment model, respectively. The S(+) CPF enantiomer predominated in plasma following both routes of administration. Mean observed clearance of R(-)-CPF (82.17 ± 13.70 mL/h·kg) was more rapid than for S(+)-CPF (27.92 ± 7.07 mL/h·kg; P < 0.001). T1/2λz was shorter for R(-)-CPF than S(+)-CPF after both i.v. (1.03 and 2.99 h, respectively) and s.c. (1.94 and 4.14 h, respectively) dosing. Mean AUC 0→∞ ratios for R(-):S(+)-CPF were approximately 1:3 for both routes of administration. Mean residence time of R(-)-CPF was shorter than of S(+)-CPF (1.06 ± 0.29 h, 3.45 ± 0.50 h; P < 0.001) and R(-)- and S(+)-CPF volumes of distribution at steady state were 85.00 ± 14.42 and 94.39 ± 18.66 mL/kg, respectively after i.v. administration. The mean s.c. bioavailability [F (%)] for both R(-)- and S(+)-CPF was high, 94.4 ± 22.8 and 91.0 ± 35.7%, respectively.

Original languageEnglish (US)
Pages (from-to)423-430
Number of pages8
JournalJournal of Veterinary Pharmacology and Therapeutics
Volume31
Issue number5
DOIs
StatePublished - Oct 2008

Fingerprint

New Zealand White rabbit
pharmacokinetics
Pharmacokinetics
Rabbits
enantiomers
dosage
intravenous injection
bioavailability
high performance liquid chromatography
rabbits
blood
sampling
carprofen
Intravenous Administration
cross-over studies
Cross-Over Studies
Biological Availability
Area Under Curve

ASJC Scopus subject areas

  • Pharmacology
  • veterinary(all)

Cite this

Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits. / Hawkins, Michelle; Taylor, I. T.; Craigmill, A. L.; Tell, Lisa A.

In: Journal of Veterinary Pharmacology and Therapeutics, Vol. 31, No. 5, 10.2008, p. 423-430.

Research output: Contribution to journalArticle

@article{832e3055b7624c58a68b94216e1c78f0,
title = "Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits",
abstract = "The enantioselective pharmacokinetics of single dose (2 mg/kg) racemic carprofen (CPF) were evaluated in adult New Zealand white rabbits after intravenous (i.v.) and subcutaneous (s.c.) dose. Six rabbits were utilized in a two-way randomized crossover study and serial blood samples were collected. Plasma CPF concentrations were determined by high-performance liquid chromatography. After i.v. and s.c. racemic CPF administration, plasma concentration-time curves were best described by a two-compartment open model and a one-compartment model, respectively. The S(+) CPF enantiomer predominated in plasma following both routes of administration. Mean observed clearance of R(-)-CPF (82.17 ± 13.70 mL/h·kg) was more rapid than for S(+)-CPF (27.92 ± 7.07 mL/h·kg; P < 0.001). T1/2λz was shorter for R(-)-CPF than S(+)-CPF after both i.v. (1.03 and 2.99 h, respectively) and s.c. (1.94 and 4.14 h, respectively) dosing. Mean AUC 0→∞ ratios for R(-):S(+)-CPF were approximately 1:3 for both routes of administration. Mean residence time of R(-)-CPF was shorter than of S(+)-CPF (1.06 ± 0.29 h, 3.45 ± 0.50 h; P < 0.001) and R(-)- and S(+)-CPF volumes of distribution at steady state were 85.00 ± 14.42 and 94.39 ± 18.66 mL/kg, respectively after i.v. administration. The mean s.c. bioavailability [F ({\%})] for both R(-)- and S(+)-CPF was high, 94.4 ± 22.8 and 91.0 ± 35.7{\%}, respectively.",
author = "Michelle Hawkins and Taylor, {I. T.} and Craigmill, {A. L.} and Tell, {Lisa A}",
year = "2008",
month = "10",
doi = "10.1111/j.1365-2885.2008.00975.x",
language = "English (US)",
volume = "31",
pages = "423--430",
journal = "Journal of Veterinary Pharmacology and Therapeutics",
issn = "0140-7783",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits

AU - Hawkins, Michelle

AU - Taylor, I. T.

AU - Craigmill, A. L.

AU - Tell, Lisa A

PY - 2008/10

Y1 - 2008/10

N2 - The enantioselective pharmacokinetics of single dose (2 mg/kg) racemic carprofen (CPF) were evaluated in adult New Zealand white rabbits after intravenous (i.v.) and subcutaneous (s.c.) dose. Six rabbits were utilized in a two-way randomized crossover study and serial blood samples were collected. Plasma CPF concentrations were determined by high-performance liquid chromatography. After i.v. and s.c. racemic CPF administration, plasma concentration-time curves were best described by a two-compartment open model and a one-compartment model, respectively. The S(+) CPF enantiomer predominated in plasma following both routes of administration. Mean observed clearance of R(-)-CPF (82.17 ± 13.70 mL/h·kg) was more rapid than for S(+)-CPF (27.92 ± 7.07 mL/h·kg; P < 0.001). T1/2λz was shorter for R(-)-CPF than S(+)-CPF after both i.v. (1.03 and 2.99 h, respectively) and s.c. (1.94 and 4.14 h, respectively) dosing. Mean AUC 0→∞ ratios for R(-):S(+)-CPF were approximately 1:3 for both routes of administration. Mean residence time of R(-)-CPF was shorter than of S(+)-CPF (1.06 ± 0.29 h, 3.45 ± 0.50 h; P < 0.001) and R(-)- and S(+)-CPF volumes of distribution at steady state were 85.00 ± 14.42 and 94.39 ± 18.66 mL/kg, respectively after i.v. administration. The mean s.c. bioavailability [F (%)] for both R(-)- and S(+)-CPF was high, 94.4 ± 22.8 and 91.0 ± 35.7%, respectively.

AB - The enantioselective pharmacokinetics of single dose (2 mg/kg) racemic carprofen (CPF) were evaluated in adult New Zealand white rabbits after intravenous (i.v.) and subcutaneous (s.c.) dose. Six rabbits were utilized in a two-way randomized crossover study and serial blood samples were collected. Plasma CPF concentrations were determined by high-performance liquid chromatography. After i.v. and s.c. racemic CPF administration, plasma concentration-time curves were best described by a two-compartment open model and a one-compartment model, respectively. The S(+) CPF enantiomer predominated in plasma following both routes of administration. Mean observed clearance of R(-)-CPF (82.17 ± 13.70 mL/h·kg) was more rapid than for S(+)-CPF (27.92 ± 7.07 mL/h·kg; P < 0.001). T1/2λz was shorter for R(-)-CPF than S(+)-CPF after both i.v. (1.03 and 2.99 h, respectively) and s.c. (1.94 and 4.14 h, respectively) dosing. Mean AUC 0→∞ ratios for R(-):S(+)-CPF were approximately 1:3 for both routes of administration. Mean residence time of R(-)-CPF was shorter than of S(+)-CPF (1.06 ± 0.29 h, 3.45 ± 0.50 h; P < 0.001) and R(-)- and S(+)-CPF volumes of distribution at steady state were 85.00 ± 14.42 and 94.39 ± 18.66 mL/kg, respectively after i.v. administration. The mean s.c. bioavailability [F (%)] for both R(-)- and S(+)-CPF was high, 94.4 ± 22.8 and 91.0 ± 35.7%, respectively.

UR - http://www.scopus.com/inward/record.url?scp=53149091687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53149091687&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2885.2008.00975.x

DO - 10.1111/j.1365-2885.2008.00975.x

M3 - Article

C2 - 19000261

AN - SCOPUS:53149091687

VL - 31

SP - 423

EP - 430

JO - Journal of Veterinary Pharmacology and Therapeutics

JF - Journal of Veterinary Pharmacology and Therapeutics

SN - 0140-7783

IS - 5

ER -